Author:
Schwartz Theresa L.,Horwood Chelsea
Reference35 articles.
1. Lagios M. Heterogeneity of ductal carcinoma in situ of the breast. J Cell Biochem. 1993;53:49–52.
2. Morrow M, Harris JR. Ductal carcinoma in situ and microinvasive carcinoma. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 521–37.
3. Han K, Nofech-Mozes S, Narod S, et al. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Clin Oncol. 2012;24:183–9.
4. Baird RM, Worth A, Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg. 1990;159:479–81.
5. Fisher ER, Leeming R, Anderson S, et al. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol. 1991;47:139–47.